April 30, 2019

Trillium Therapeutics Shares Corporate Update

Trillium Therapeutics issued an update to shareholders on new appointments and a corporate strategy update.
February 22, 2019

Trillium Announces Pricing of US$15 Million Public Offering of Common Share Units

Trillium Therapeutics (NASDAQ:TSX:TRIL) has announced it has priced its underwitten public offering of 6.55 million common shares of the company...